M-EZETIMIBE DIN 02467437
Health Canada record
| Active ingredient(s) | EZETIMIBE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C10AX09 EZETIMIBE |
| Original market date | 14-Dec-2017 |
| Current status date | 14-Dec-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mantra Pharma Inc. — licence 101740, currently licensed, last inspection rating C (2023-05-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EZETIMIBE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02425610 | ACH-EZETIMIBE | ACCORD HEALTHCARE INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02475898 | AG-EZETIMIBE | ANGITA PHARMA INC. | Tablet | EZETIMIBE 10 MG | Marketed |
| 02427826 | APO-EZETIMIBE | APOTEX INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02469286 | AURO-EZETIMIBE | AURO PHARMA INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02425211 | BIO-EZETIMIBE | BIOMED PHARMA | Tablet | EZETIMIBE 10 MG | Marketed |
| 02431300 | EZETIMIBE | SANIS HEALTH INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02478544 | EZETIMIBE | LABORATOIRE RIVA INC. | Tablet | EZETIMIBE 10 MG | Marketed |
| 02422549 | EZETIMIBE | PRO DOC LIMITEE | Tablet | EZETIMIBE 10 MG | Marketed |
| 02247521 | EZETROL | ORGANON CANADA INC. | Tablet | EZETIMIBE 10 MG | Marketed |
| 02421119 | IPG-EZETIMIBE | MARCAN PHARMACEUTICALS INC | Tablet | EZETIMIBE 10 MG | Approved |
| 02423235 | JAMP-EZETIMIBE | JAMP PHARMA CORPORATION | Tablet | EZETIMIBE 10 MG | Marketed |
| 02422662 | MAR-EZETIMIBE | MARCAN PHARMACEUTICALS INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02423243 | MINT-EZETIMIBE | MINT PHARMACEUTICALS INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02571218 | NB-EZETIMIBE | NB PHARMA INC. | Tablet | EZETIMIBE 10 MG | Approved |
| 02536420 | NRA-EZETIMIBE TABLETS | NORA PHARMA INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02416409 | PMS-EZETIMIBE | PHARMASCIENCE INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02416778 | SANDOZ EZETIMIBE | SANDOZ CANADA INCORPORATED | Tablet | EZETIMIBE 10 MG | Marketed |
| 02419548 | SPC-EZETIMIBE | SUN PHARMA CANADA INC | Tablet | EZETIMIBE 10 MG | Marketed |
| 02354101 | TEVA-EZETIMIBE | TEVA CANADA LIMITED | Tablet | EZETIMIBE 10 MG | Marketed |
| 02414716 | ACT EZETIMIBE | ACTAVIS PHARMA COMPANY | Tablet | EZETIMIBE 10 MG | Cancelled Post Market |
| 02429659 | EZETIMIBE | SIVEM PHARMACEUTICALS ULC | Tablet | EZETIMIBE 10 MG | Dormant |
| 02460750 | GLN-EZETIMIBE | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | EZETIMIBE 10 MG | Dormant |
| 02378035 | MYLAN-EZETIMIBE | MYLAN PHARMACEUTICALS ULC | Tablet | EZETIMIBE 10 MG | Cancelled Post Market |
| 02481669 | NRA-EZETIMIBE | NORA PHARMA INC | Tablet | EZETIMIBE 10 MG | Cancelled Post Market |
| 02425238 | PRIVA-EZETIMIBE | NORA PHARMA INC | Tablet | EZETIMIBE 10 MG | Cancelled Post Market |
| 02424436 | RIVA-EZETIMIBE | LABORATOIRE RIVA INC. | Tablet | EZETIMIBE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19685 | 2017-08-18 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for EZETIMIBE
33 active FDA Drug Master Files.
Request a quote for M-EZETIMIBE